will ince

Consultant/Assistant Professor

Hôpital Fondation Adolphe de Rothschild

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Will Ince is an Assistant Professor at Addenbrooke's Hospital in the United Kingdom. His research focuses on oncology, particularly in the areas of renal cell carcinoma and immune checkpoint inhibitors in head and neck cancers. He has authored several recent articles exploring the efficacy of tivozanib monotherapy and combination therapies in metastatic renal cell carcinoma, as well as the implications of real-world data in cancer treatment.

Articles (7)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Grant D. Stewart

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

will ince

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Correction to: Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis

Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives

Squamous cell carcinoma of the oral cavity, oropharynx and upper oesophagus

Activity of Immunotherapy Regimens on Primary Renal Tumours: A Systematic Review

Combination therapies in clinical trials for renal cell carcinoma: how could they impact future treatments?

What is the Role of Real-World Data in Metastatic Renal Cell Cancer?

Collaborators (1)

Grant D. Stewart

Make your next move.